GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins September 04, 2024
Displaying entries 31551 - 31600 of 39437 in total
PDB ID UniProt ID Title Descriptor ▲
8ANA A0A7L6YWH1 Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit
8ANA C3SQU2 Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit
8ANA D8A1N0 Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit
8ANA D6IEK6 Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit
8ANA C3SR17 Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit
8ANA C3SFP2 Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit
8ANA A0A656YGQ7 Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit
8ANA C3SQZ2 Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit
8ANA P02413 Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit
8ANA A0A0H3EMH6 Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit
8ANA A0A1X3JBW6 Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit
8ANA A0A514EKV0 Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit
8ANA A0A370V6W8 Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit
8ANA A0A378BCJ4 Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit
8ANA A0A0E2L2H1 Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit
8ANA A0A0F6B7N1 Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit
8ANA D7Y3D8 Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit
8ANA S1E9P3 Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit
8ANA P68919 Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit
8ANA C3SSG7 Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit
8ANA C3SME2 Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit
8ANA P0A7M6 Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit
8ANA C3SR32 Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit
8ANA A0A657HW13 Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit
8BEV P0DTC2 Cryo-EM structure of SARS-CoV-2 spike (HexaPro variant) in complex with nanobody W25 (map 3, focus refinement on RBD, W25 and adjacent NTD)
8BEV 8BEV Cryo-EM structure of SARS-CoV-2 spike (HexaPro variant) in complex with nanobody W25 (map 3, focus refinement on RBD, W25 and adjacent NTD)
8BGG P0DTC2 Cryo-EM structure of SARS-CoV-2 spike (Omicron BA.1 variant) in complex with nanobody W25 (map 5, focus refinement on RBD, W25 and adjacent NTD)
8BGG 8BGG Cryo-EM structure of SARS-CoV-2 spike (Omicron BA.1 variant) in complex with nanobody W25 (map 5, focus refinement on RBD, W25 and adjacent NTD)
8A1F Q15262 Human PTPRK N-terminal domains MAM-Ig-FN1
8AQW P01863 BA.4/5 SARS-CoV-2 Spike bound to mouse ACE2 (local)
8AQW Q8R0I0 BA.4/5 SARS-CoV-2 Spike bound to mouse ACE2 (local)
8AQW P10104 BA.4/5 SARS-CoV-2 Spike bound to mouse ACE2 (local)
8AQW P0DTC2 BA.4/5 SARS-CoV-2 Spike bound to mouse ACE2 (local)
7TU9 O93430 Alpha1/BetaB Heteromeric Glycine Receptor in Strychnine-Bound State
7TU9 Q6DC22 Alpha1/BetaB Heteromeric Glycine Receptor in Strychnine-Bound State
7TVI O93430 Alpha1/BetaB Heteromeric Glycine Receptor in Glycine-Bound State
7TVI Q6DC22 Alpha1/BetaB Heteromeric Glycine Receptor in Glycine-Bound State
7X93 P0DTC2 The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab765
7X93 7X93 The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab765
7X94 P0DTC2 The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab712
7X94 7X94 The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab712
7X95 P0DTC2 The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab709
7X95 7X95 The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab709
7X96 P0DTC2 The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab847
7X96 7X96 The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab847
7Z3R P41160 Crystal structure of the mouse leptin:LepR-IgCRH2 complex to 2.95 A resolution.
7Z3R P48356 Crystal structure of the mouse leptin:LepR-IgCRH2 complex to 2.95 A resolution.
7Z6T A1C4M2 Aspergillus clavatus M36 protease without the propeptide
8BBO Q6GMX6 SARS-CoV-2 Delta-RBD complexed with BA.2-36 Fab
8BBO P0DOX7 SARS-CoV-2 Delta-RBD complexed with BA.2-36 Fab

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024